Viewing nowLipistop 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

MFDS item code 201000637 · Approved 2010.01.19 · Insurance code 642903770
Improvement of hyperlipidemia (e.g., familial hyperlipidemia in children); prevention of cardiovascular diseases (e.g., myocardial infarction)
This medication is used for adults and some pediatric patients looking to reduce the risk of cardiovascular disease. It helps lower the risk of serious cardiovascular events such as myocardial infarction and stroke in patients with various risk factors for heart disease. It also improves the condition of patients after vascular procedures or with chronic stable angina and reduces the risk of hospitalization due to congestive heart failure. For patients with hyperlipidemia, it reduces total cholesterol and LDL cholesterol while increasing HDL cholesterol, thereby improving blood lipid levels. This medication is primarily used in conjunction with diet or when diet alone is insufficient, and is also helpful for pediatric patients aged 10 to 17 with specific hypercholesterolemia. Overall, it is used to maintain patients' health by reducing the risk of cardiovascular disease and improving blood lipids.
Before and during treatment with atorvastatin, patients should follow a standard cholesterol-lowering diet. The medicine may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol levels be used when initiating treatment and evaluating treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia: The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. Older adults: The efficacy and safety in older patients aged 70 years or older are generally similar to those in the usual adult patient population.
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goals for each patient. The dose should be adjusted at intervals of 4 weeks or more.
This medication may cause adverse effects on muscles, so if there are severe muscle pain or weakness, or significant increases in creatine kinase levels, the medication should be discontinued immediately and a doctor should be consulted. Patients with liver function problems or elevated liver enzymes should not use this medication, and liver health should be regularly monitored. Pregnant women or women who may become pregnant, and breastfeeding mothers should not take this medication, and women of childbearing age should use appropriate contraception while taking it. Children, especially those under 10 years old, should not take this medication, and the safety and efficacy in pediatric patients aged 10 to 17 have not been sufficiently studied. Patients with a history of alcohol abuse or liver disease should use this medication cautiously, and the elderly or patients with impaired kidney function are at higher risk for muscle-related side effects and should be careful. Due to many drug interactions, especially with certain antibiotics, antifungals, antivirals, or specific lipid-lowering agents, it is essential to inform a doctor or pharmacist when taking them, as dosage adjustments may be necessary. If symptoms such as muscle pain, fatigue, or fever occur during treatment, medical personnel should be notified immediately, and regular blood tests to monitor liver function and muscle status are essential. There is no specific antidote for overdose, so symptomatic treatment should be provided and liver function and muscle enzyme levels should be carefully monitored. This medication should be kept out of reach of children and should not be removed from its original container to another container. If severe allergic reactions such as skin rash, hives, fever, or mucosal damage occur, the medication should be discontinued immediately, and emergency treatment sought. As there may be an increased risk of diabetes, blood sugar levels should be monitored regularly and appropriate treatment should be sought if necessary.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain room temperature between 1 degree and 30 degrees Celsius.
White round film-coated tablet
30 tablets (10 tablets x 3)/Alu-Alu, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.